IN148930B
(fr)
|
1977-09-19 |
1981-07-25 |
Hoffmann La Roche |
|
AT375365B
(de)
*
|
1978-04-14 |
1984-07-25 |
Haessle Ab |
Verfahren zur herstellung von neuen 2-pyridylalkyl-sulfinyl-benzimidazolen, von deren hydraten, stereoisomeren und salzen
|
AT406119B
(de)
*
|
1978-04-14 |
2000-02-25 |
Haessle Ab |
Verfahren zur herstellung von granulaten bzw. tabletten oder kapseln zur oralen verabreichung
|
SE7804231L
(sv)
*
|
1978-04-14 |
1979-10-15 |
Haessle Ab |
Magsyrasekretionsmedel
|
US4359465A
(en)
*
|
1980-07-28 |
1982-11-16 |
The Upjohn Company |
Methods for treating gastrointestinal inflammation
|
CH644116A5
(de)
*
|
1980-08-21 |
1984-07-13 |
Hoffmann La Roche |
Imidazolderivate.
|
IL66340A
(en)
*
|
1981-08-13 |
1986-08-31 |
Haessle Ab |
Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
|
US4472409A
(en)
*
|
1981-11-05 |
1984-09-18 |
Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung |
2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
|
JPS58135881A
(ja)
*
|
1981-11-05 |
1983-08-12 |
ビク−グルデン・ロムベルク・ヘミツシエ・フアブリク・ゲゼルシヤフト・ミト・ベシユレンクテル・ハフツング |
置換ベンズイミダゾ−ル類、その製造方法と利用、およびこれを含む医薬
|
DE3216843C2
(de)
*
|
1982-05-05 |
1986-10-23 |
Ludwig Heumann & Co GmbH, 8500 Nürnberg |
3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
SE8300736D0
(sv)
*
|
1983-02-11 |
1983-02-11 |
Haessle Ab |
Novel pharmacologically active compounds
|
SE8301182D0
(sv)
*
|
1983-03-04 |
1983-03-04 |
Haessle Ab |
Novel compounds
|
HU191756B
(en)
*
|
1983-05-03 |
1987-04-28 |
Byk Gulden Lomberg Chem Fab |
Process for preparing new fluoro-alkoxy-benzimidazole derivatives
|
HU195220B
(en)
*
|
1983-05-03 |
1988-04-28 |
Byk Gulden Lomberg Chem Fqb |
Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
|
CA1259070A
(fr)
*
|
1983-07-01 |
1989-09-05 |
Upjohn Company (The) |
Derives de substitution de 2-¬noyaux condenses (3,4- 4,5-, 5,6-)-pyridylalcoylenesulfinyl|- benzimidazoles
|
US5077407A
(en)
*
|
1983-07-01 |
1991-12-31 |
The Upjohn Company |
Substituted 2-[monoannelated (3,4-,4,5-, and 5,6-) pyridylalkylenesulfinyl]benzimidazoles
|
DE3333314A1
(de)
*
|
1983-09-15 |
1985-03-28 |
Hoechst Ag, 6230 Frankfurt |
Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
|
US4575554A
(en)
*
|
1983-12-05 |
1986-03-11 |
The Upjohn Company |
Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
|
PH23995A
(en)
*
|
1984-01-09 |
1990-02-09 |
Janssen Pharmaceutica Nv |
4((bicycle heterocyclyl)-methyl and hetero)piperidines
|
DE3585252D1
(de)
*
|
1984-07-06 |
1992-03-05 |
Fisons Plc |
Benzimidazole, und verfahren zu deren herstellung, deren formulierung und verwendung als magensaeuresekretionshemmende verbindungen.
|
SE8404065D0
(sv)
*
|
1984-08-10 |
1984-08-10 |
Haessle Ab |
Novel biologically active compounds
|
JPS6150978A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
JPS6150979A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
US4619997A
(en)
*
|
1984-09-06 |
1986-10-28 |
The Upjohn Company |
Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
|
AU568441B2
(en)
*
|
1984-09-24 |
1987-12-24 |
Upjohn Company, The |
2-(pyridylalkenesulfinyl) benzimidazole derivatives
|
KR890000387B1
(ko)
*
|
1984-09-24 |
1989-03-16 |
디 엎존 캄파니 |
2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
|
DE3579436D1
(de)
*
|
1984-12-18 |
1990-10-04 |
Otsuka Pharma Co Ltd |
Tetrahydrochinolin- derivate, verfahren zu deren herstellung und diese enthaltende antimagengeschwuerzusammensetzungen.
|
GB8526154D0
(en)
*
|
1985-02-06 |
1985-11-27 |
Kotobuki Seiyaku Co Ltd |
2-substituted cyclo-heptoimidazoles
|
DK8600939A
(fr)
*
|
1985-03-05 |
1986-09-06 |
|
|
FI861772A
(fi)
*
|
1985-05-07 |
1986-11-08 |
Chemie Linz Ag |
Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
|
US5869513A
(en)
*
|
1985-05-24 |
1999-02-09 |
G. D. Searle & Co. |
2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
|
EP0204215B1
(fr)
|
1985-05-24 |
1993-08-11 |
G.D. Searle & Co. |
[(1H-benzimidazol-yl-2-sulfonyl)méthyl]-2-benzèneamines
|
US4738975A
(en)
*
|
1985-07-02 |
1988-04-19 |
Takeda Chemical Industries, Ltd. |
Pyridine derivatives, and use as anti-ulcer agents
|
DK337086A
(da)
*
|
1985-08-12 |
1987-02-13 |
Hoffmann La Roche |
Benzimidazolderivater
|
AR243167A1
(es)
|
1985-08-24 |
1993-07-30 |
Hoechst Ag |
Procedimiento para la preparacion de toluidinas sustituidas.
|
SE8505112D0
(sv)
*
|
1985-10-29 |
1985-10-29 |
Haessle Ab |
Novel pharmacological compounds
|
US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
US6749864B2
(en)
*
|
1986-02-13 |
2004-06-15 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
SE8600658D0
(sv)
*
|
1986-02-14 |
1986-02-14 |
Haessle Ab |
Novel composition of matter
|
EP0234485B1
(fr)
*
|
1986-02-20 |
1992-04-01 |
Hoechst Aktiengesellschaft |
Dérivés substitués du thiénoimidazole, procédés pour leur préparation, compositions pharmaceutiques les contenant et leur application comme inhibiteurs de la sécrétion du suc gastrique
|
WO1987005296A1
(fr)
*
|
1986-03-07 |
1987-09-11 |
Pfizer Inc. |
2-[(2-pyridyl)methylsulfinyl]thienoimidazoles et composes apparentes utilises en tant qu'agents de traitement ou de prevention des ulceres
|
EP0239129B1
(fr)
*
|
1986-03-28 |
1991-09-25 |
Otsuka Pharmaceutical Co., Ltd. |
Composés hydroquinoléine, compositions les contenant et procédé pour leur préparation
|
US4772619A
(en)
*
|
1986-07-17 |
1988-09-20 |
G. D. Searle & Co. |
[(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
|
US4687775A
(en)
*
|
1986-07-17 |
1987-08-18 |
G. D. Searle & Co. |
2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
|
US4721718A
(en)
*
|
1986-08-18 |
1988-01-26 |
G. D. Searle & Co. |
2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
|
SE8604998D0
(sv)
|
1986-11-21 |
1986-11-21 |
Haessle Ab |
Novel pharmacological compounds
|
NZ234564A
(en)
|
1986-11-21 |
1991-04-26 |
Haessle Ab |
1-substituted benzimidazoles and pharmaceutical compositions
|
DE3639926A1
(de)
*
|
1986-11-22 |
1988-06-01 |
Hoechst Ag |
Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
|
US5330982A
(en)
*
|
1986-12-17 |
1994-07-19 |
Glaxo Group Limited |
Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
|
GB8630080D0
(en)
*
|
1986-12-17 |
1987-01-28 |
Glaxo Group Ltd |
Medicaments
|
DE3723327A1
(de)
*
|
1987-07-15 |
1989-02-02 |
Hoechst Ag |
Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
|
AU2621888A
(en)
*
|
1987-10-30 |
1989-05-23 |
Aktiebolaget Hassle |
Omeprazole for treatment of diseases related to bone loss
|
KR920003928B1
(ko)
*
|
1988-09-20 |
1992-05-18 |
히사미쯔세이야꾸 가부시기가이샤 |
신규의 디벤즈[b,e]옥세핀유도체
|
EG19302A
(en)
*
|
1988-12-22 |
1994-11-30 |
Haessle Ab |
Compound with gastric acid inhibitory effect and process for its preparation
|
SE8804629D0
(sv)
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New therapeutically active compounds
|
SE8804628D0
(sv)
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New compounds
|
ATE110069T1
(de)
*
|
1989-11-29 |
1994-09-15 |
Toa Eiyo Ltd |
Cycloheptenopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende antiulkusmitteln.
|
US5274099A
(en)
*
|
1989-12-20 |
1993-12-28 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US4965269A
(en)
*
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
US5049674A
(en)
|
1989-12-20 |
1991-09-17 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
JP2524420B2
(ja)
*
|
1990-05-16 |
1996-08-14 |
明治製菓株式会社 |
ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
|
SE9002206D0
(sv)
|
1990-06-20 |
1990-06-20 |
Haessle Ab |
New compounds
|
US5364875A
(en)
*
|
1992-05-11 |
1994-11-15 |
The Du Pont Merck Pharmaceutical Company |
Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
|
HUT71885A
(en)
*
|
1992-07-08 |
1996-02-28 |
Monsanto Co |
Process for preparing a composition containing benzimidazoles for treatment stomach ulcer in swine
|
CZ284249B6
(cs)
*
|
1992-07-28 |
1998-10-14 |
Astra Aktiebolag |
Injekce a injekční souprava obsahující omeprazol a jeho analogy
|
TW280770B
(fr)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
US5945425A
(en)
*
|
1994-04-29 |
1999-08-31 |
G.D. Searle & Co. |
Method of using (H+ /K+)ATPase inhibitors as antiviral agents
|
AU6369696A
(en)
|
1995-07-17 |
1997-02-18 |
Fuji Photo Film Co., Ltd. |
Benzimidazole compounds
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
CN1093855C
(zh)
*
|
1995-09-21 |
2002-11-06 |
帕斯医药股份有限公司 |
新的含有对酸不稳定的奥美拉唑的组合物及其制备方法
|
KR100570104B1
(ko)
*
|
1997-07-11 |
2006-04-11 |
에자이 가부시키가이샤 |
피리딘 유도체의 제조방법
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
GB9805558D0
(en)
*
|
1998-03-17 |
1998-05-13 |
Knoll Ag |
Chemical process`
|
KR101032289B1
(ko)
|
1998-05-18 |
2011-05-06 |
다케다 야쿠힌 고교 가부시키가이샤 |
미세과립
|
CN100396675C
(zh)
|
1998-08-10 |
2008-06-25 |
加利福尼亚州大学董事会 |
质子泵抑制剂的前药
|
US6093734A
(en)
*
|
1998-08-10 |
2000-07-25 |
Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin |
Prodrugs of proton pump inhibitors
|
US6166213A
(en)
*
|
1998-08-11 |
2000-12-26 |
Merck & Co., Inc. |
Omeprazole process and compositions thereof
|
US6733778B1
(en)
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
DE60015607T2
(de)
|
2000-02-24 |
2005-11-10 |
Kopran Research Laboratories Ltd. |
Oral verabreichbare säurebeständige geschwürbehandelnde benzimidazolderivate
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
EP1437352A4
(fr)
*
|
2001-09-25 |
2004-12-08 |
Takeda Chemical Industries Ltd |
Compose de benzymidazole, procede de production et d'utilisation de celui-ci
|
EP2258351B1
(fr)
|
2001-10-17 |
2013-06-19 |
Takeda Pharmaceutical Company Limited |
Granules contenant lansoprazol en grande quantité
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
ATE437642T1
(de)
*
|
2002-06-14 |
2009-08-15 |
Takeda Pharmaceutical |
Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
|
RU2292342C2
(ru)
*
|
2002-07-19 |
2007-01-27 |
Уинстон Фармасьютикалс ЛЛС. |
Производные бензимидазола и их применение в качестве пролекарств ингибиторов протонного насоса
|
US7211590B2
(en)
*
|
2002-08-01 |
2007-05-01 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
ES2534713T3
(es)
|
2002-10-16 |
2015-04-27 |
Takeda Pharmaceutical Company Limited |
Preparaciones sólidas estables
|
US8802139B2
(en)
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
JP2007504261A
(ja)
*
|
2003-09-03 |
2007-03-01 |
エイジーアイ・セラピューティクス・リサーチ・リミテッド |
プロトンポンプ阻害剤製剤、並びに当該製剤を製造及び使用する方法関連出願の表示
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
US20060241037A1
(en)
*
|
2003-10-03 |
2006-10-26 |
Allergan Inc. |
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
EP1716136A1
(fr)
|
2004-02-11 |
2006-11-02 |
Ulkar Kimya Sanayii Ve Ticaret A.S. |
Pyridine benzimidazole sulphoxides de grande pureté
|
AU2005216862A1
(en)
*
|
2004-02-18 |
2005-09-09 |
Allergan, Inc. |
Compositions comprising prodrugs of proton pump inhibitors
|
JP2007523164A
(ja)
*
|
2004-02-18 |
2007-08-16 |
アラーガン、インコーポレイテッド |
プロトンポンプインヒビターに関連する化合物の静脈内投与のための方法および組成物
|
CA2561700A1
(fr)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
CN102775388B
(zh)
|
2004-09-13 |
2016-01-20 |
武田药品工业株式会社 |
氧化化合物的制备方法和制备装置
|
CA2784881C
(fr)
|
2005-02-25 |
2016-02-09 |
Takeda Pharmaceutical Company Limited |
Procede de fabrication de granules
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US8486450B2
(en)
|
2005-12-28 |
2013-07-16 |
Takeda Pharmaceutical Company Limited |
Method of producing solid preparation disintegrating in the oral cavity
|
US20070199890A1
(en)
*
|
2006-02-27 |
2007-08-30 |
Agion Technologies, Inc. |
Antimicrobial activated carbon and use thereof
|
JP5457830B2
(ja)
|
2006-04-03 |
2014-04-02 |
オディディ,イサ |
オルガノゾル被膜を含む制御放出送達デバイス
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US7786309B2
(en)
*
|
2006-06-09 |
2010-08-31 |
Apotex Pharmachem Inc. |
Process for the preparation of esomeprazole and salts thereof
|
US20100317689A1
(en)
*
|
2006-09-19 |
2010-12-16 |
Garst Michael E |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
GB2459393B
(en)
|
2006-10-05 |
2010-09-08 |
Santarus Inc |
Novel capsule formulation for the proton pump inhibitor omeprazole
|
MX2009004475A
(es)
|
2006-10-27 |
2009-08-12 |
Univ Missouri |
Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
|
NZ578204A
(en)
|
2006-12-22 |
2012-05-25 |
Ironwood Pharmaceuticals Inc |
Compositions comprising bile acid sequestrants for treating esophageal disorders
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
WO2013031620A1
(fr)
|
2011-08-26 |
2013-03-07 |
国立大学法人名古屋大学 |
Promoteur d'ostéogenèse et son utilisation
|
WO2013088109A1
(fr)
|
2011-12-16 |
2013-06-20 |
Oxagen Limited |
Combinaison d'un antagoniste de crth2 et d'un inhibiteur de pompe à protons pour le traitement de l'œsophagite à éosinophiles
|
BR112015016917B1
(pt)
|
2013-01-15 |
2022-08-30 |
Ironwood Pharmaceuticals, Inc |
Forma de dosagem oral de retenção gástrica, e, uso de um sequestrante de ácido biliar
|
WO2016126625A1
(fr)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Méthodes de traitement de troubles gastro-intestinaux supérieurs de gerd réfractaire à ppi
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
WO2017145146A1
(fr)
|
2016-02-25 |
2017-08-31 |
Dexcel Pharma Technologies Ltd. |
Compositions comprenant des inhibiteurs de la pompe à protons
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
TWI659022B
(zh)
*
|
2016-09-14 |
2019-05-11 |
國立臺灣大學 |
作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物
|
WO2024075017A1
(fr)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition de calcification de valve aortique
|